Guben Kechuan Granules

Developed for: bronchiectasis · chronic obstructive pulmonary disease
Investigated by: Affiliated Yueqing Hospital of Wenzhou Medical University · Cuiling Feng · Jinan Hospital of Integrated Traditional Chinese and Western Medicine · Jinhua Central Hospital · Linfen Central Hospital · Second Affiliated Hospital, School of Medicine, Zhejiang University
+4 more
· Shanghai Zhongshan Hospital · Traditional Chinese Medicine Hospital of Changji Hui Autonomous Prefecture, Xinjiang · ZhuZhou Central Hospital · Zhuhai Hospital of Integrated Traditional Chinese and Western Medicine

202620272028

Phase	Registry id	Dates	Indication	Sponsor	Status	Outcome
Phase 41 trial
Phase 4	NCT07114120	Jul 2025 → Oct 2027 expected	bronchiectasis	Second Affiliated Hospital, School of Medicine, Zhejiang University	Recruiting	No outcome recorded
Phase not applicable1 trial
—	NCT07456813	Mar 2026 → Dec 2027 expected	chronic obstructive pulmonary disease	Cuiling Feng	Not yet recruiting	No outcome recorded

Every value below carries the sentence it was read from. 2 sources stand behind the page.

Field	Value	Cited text
Known as	Guben Kechuan Granules	ClinicalTrials.gov intervention name — accepted as the source's own label NCT07456813 ↗ 1 NCT07114120 ↗
Route	Oral	“The granules were dissolved in warm water for oral administration at a dosage of 2 g each time, 3 times a day, for 12 consecutive weeks.” NCT07456813 ↗